The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 2 study of botensilimab and AGEN1423, an anti-CD73-TGFß-trap bifunctional antibody, in subjects with advanced pancreatic cancer.
 
Julia Berg
Employment - Bristol-Myers Squibb (I); Terremoto Biosciences (I)
Stock and Other Ownership Interests - Bristol-Myers Squibb (I)
 
Andrea Bullock
Stock and Other Ownership Interests - Medtronic
Consulting or Advisory Role - Agenus; Sirtex Medical
Research Funding - Agenus (Inst); AstraZeneca (Inst); Geistlich Pharma (Inst); Ipsen (Inst); Oncomatryx (Inst); Panova (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - Agenus
 
Peter Whooley
No Relationships to Disclose
 
Mary Linton Peters
Stock and Other Ownership Interests - Abbott Laboratories; Amgen; Johnson & Johnson; Lilly; Medtronic; Procter & Gamble
Research Funding - AstraZeneca (Inst); Merck (Inst)
 
Nora Horick
Employment - Mass General Brigham; Northwest Biotherapeutics (I)
Stock and Other Ownership Interests - Northwest Biotherapeutics (I)
Consulting or Advisory Role - American Society of Clinical Oncology
Patents, Royalties, Other Intellectual Property - An immediate family member holds patents, has patents pending, and receives royalties from a technology relating to health or medicine. (I)
 
Jessica Zerillo
Employment - Harvard Medical Faculty Physicians/ BIDMC
Expert Testimony - CRICO
 
Ahmed Rattani
Employment - Beth Israel Deaconess Medical Center; Johnson & Johnson/MedTech (I)
Stock and Other Ownership Interests - Actinium Pharmaceuticals; Agenus; Bicycle Therapeutics; Compass Therapeutics; ImmunityBio; Macrogenics; Pliant; Vertex
Consulting or Advisory Role - AstraZeneca/MedImmune; Healthcare Views by Fusion; Magnolia Innovation
Research Funding - National Institute of General Medical Sciences (NIGMS); National Institutes of Health; National Cancer Institute (NCI)
 
Benjamin Schlechter
Consulting or Advisory Role - Agenus; AstraZeneca; Janssen; Quercegen Pharmaceuticals
 
Selma Sinanovic
No Relationships to Disclose
 
Jane Martin
No Relationships to Disclose
 
Casey Montgomery
No Relationships to Disclose
 
Elizabeth Eaton
No Relationships to Disclose
 
Monika Vyas
No Relationships to Disclose
 
Taru Muranen
No Relationships to Disclose
 
Manuel Hidalgo
Leadership - BMS; Guardant Health
Stock and Other Ownership Interests - Champions Oncology; InxMed; Nelum Corp.
Honoraria - Champions Oncology; Velavigo; Velavigo
Consulting or Advisory Role - InxMed; Oncomatrix
Research Funding - Incyte; Ranok Therapeutics; TopAl
Patents, Royalties, Other Intellectual Property - Royalties from Myriad for PALB2 patent
Travel, Accommodations, Expenses - BMS; Guardant Health
 
Bruno Bockorny
Honoraria - BiolineRx; Enlivex Therapeutics Ltd
Consulting or Advisory Role - Blueprint Medicines; SpringWorks Therapeutics
Research Funding - Agenus (Inst); Nanoview Diagnostics
Expert Testimony - Foster & Eldridge LLP; Phelps Dunbar, LLP
Travel, Accommodations, Expenses - Agenus; ERYTECH Pharma
Other Relationship - N1X10